Policy & Regulation
16 January 2026 - Swedish biopharmaceutical company Sobi (STO: SOBI) said on Friday that the European Commission has approved Aspaveli (pegcetacoplan) for use in adults and adolescents aged 12 to 17 w...
16 January 2026 - Frontage Laboratories Inc, a US-based contract development and manufacturing organisation (CDMO) and subsidiary of Frontage Holdings Corporation (HKEX:1521), announced on Thursday th...
15 January 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday that China's National Medical Products Administration has approved two Sanofi-licen...
15 January 2026 - US-based AVEO Oncology, an LG Chem (KRX:051910) company, announced on Wednesday that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzu...
15 January 2026 - Precision medicine reporting solutions company GenomOncology (GO) announced on Wednesday that it has formed a strategic partnership with Oregon Health & Science University's...
15 January 2026 - Italian pharmaceutical company Alfasigma S.p.A. announced on Wednesday that it has formed a strategic partnership with German biotechnology company Innovative Molecules GmbH.Under th...